These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 14154337)

  • 21. [The onset of psychiatric disorders and Wilson's disease].
    Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
    Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ceruloplasmin in psychiatric research].
    SCHOU M
    Nord Med; 1960 Feb; 63():168-71. PubMed ID: 14443507
    [No Abstract]   [Full Text] [Related]  

  • 23. [Use of radioactive copper and of radioactive zinc for psychiatric diagnosis].
    Czerniak P; Zwas ST
    Ann Med Psychol (Paris); 1976 Apr; 134(4):566-76. PubMed ID: 952438
    [No Abstract]   [Full Text] [Related]  

  • 24. [HEPATOLENTICULAR DEGENERATION, ACUTE ANEMIA AND HEPATIC INSUFFICIENCY LONG PRECEDING THE NEUROLOGICAL SYMPTOMS].
    TURPIN R; CAILLE B; LAFOURCADE J; JEROME H; BOUTELIER D; DEFRANOUX A
    Ann Pediatr (Paris); 1963; 10():277-83. PubMed ID: 14126013
    [No Abstract]   [Full Text] [Related]  

  • 25. Further investigations on ceruloplasmin in hepatolenticular degeneration and on the effect of copper on oxidase activity of ceruloplasmin.
    Wald I; Galewicz A; Górska D
    Pol Med J; 1972; 11(3):733-9. PubMed ID: 5047986
    [No Abstract]   [Full Text] [Related]  

  • 26. EEG STUDIES ON CEREBRAL CIRCULATORY DISTURBANCES IN MAN. I. RESULTS DUE TO CAROTID COMPRESSION TEST.
    WADA T; OHNUMA T; OHSAWA T
    Seishin Shinkeigaku Zasshi; 1963 Jul; 17():113-28. PubMed ID: 14098972
    [No Abstract]   [Full Text] [Related]  

  • 27. HEPATOLENTICULAR DEGENERATION; CLINICAL AND BIOCHEMICAL STUDY OF THREE CASES.
    CANELAS HM; ESCALANTE OD; DE JORGE FB; ROCHA-QINTAO EC
    Arq Neuropsiquiatr; 1963 Dec; 21():229-50. PubMed ID: 14119988
    [No Abstract]   [Full Text] [Related]  

  • 28. [Test of stimulation of ceruloplasmin activity and copper concentration as affected by diphenylhydantoin (phenytoin, TSC) in the diagnosis of hepatolenticular degeneration].
    Pakszys W; Ligezińska B; Szymański H
    Pol Tyg Lek; 1982 Nov; 37(45):1353-7. PubMed ID: 7163091
    [No Abstract]   [Full Text] [Related]  

  • 29. [WILSON'S DISEASE. HISTORICAL PROGRESS IN ITS STUDY, AND FUTURE RESEARCH WITH SPECIAL REFERENCE TO ABNORMALITIES OF COPPER METABOLISM].
    OGIHARA K
    Sogo Igaku; 1963 Sep; 20():649-54. PubMed ID: 14057196
    [No Abstract]   [Full Text] [Related]  

  • 30. [The clinical characteristics and differential diagnosis of hyperkinetic forms of multiple sclerosis].
    Chernigovskaia NV
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(1):23-7. PubMed ID: 5425793
    [No Abstract]   [Full Text] [Related]  

  • 31. [Features of the course and disorders of copper and ceruloplasmin metabolism in hepatolenticular degeneration].
    Davidenkova EF; Neĭfakh SA; Butomo IV; Mashkov BA; Lapchenkov VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(7):982-90. PubMed ID: 5598796
    [No Abstract]   [Full Text] [Related]  

  • 32. Ceruloplasmin activity and copper levels in the serum of children with schizophrenia.
    BAKWIN RM
    J Am Med Womens Assoc; 1961 Jul; 16():522-3. PubMed ID: 13686173
    [No Abstract]   [Full Text] [Related]  

  • 33. [Copper, ceruloplasmin and the pathogenesis of hepatolenticular degeneration].
    Chromý K
    Cas Lek Cesk; 1965 Oct; 104(43):1173-7. PubMed ID: 5322100
    [No Abstract]   [Full Text] [Related]  

  • 34. Studies on the oxidase properties of ceruloplasmin: factors in normal and Wilson's-disease serum affecting oxidase activity.
    WALSHE JM
    J Clin Invest; 1963 Jul; 42(7):1048-53. PubMed ID: 13998657
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of the blood serum from subjects with hepatolenticular degeneration on the ceruloplasmin activity in the serum of normal and schizophrenic subjects].
    Puzyński S; Kalinowski A
    Neurol Neurochir Psychiatr Pol; 1966 Aug; 16(8):885-90. PubMed ID: 5969522
    [No Abstract]   [Full Text] [Related]  

  • 36. Molecular pathology of ceruloplasmin.
    Neifakh SA; Vasilets IM; Shavlovskii MM
    Mol Biol; 1971; 5(6):739-42. PubMed ID: 5005463
    [No Abstract]   [Full Text] [Related]  

  • 37. Ceruloplasmin, copper and Wilson's disease.
    KAWAI T
    Bull Univ Miami Sch Med Jackson Meml Hosp; 1962; 16():89-96. PubMed ID: 14031483
    [No Abstract]   [Full Text] [Related]  

  • 38. BIOCHEMICAL ASPECTS OF COPPER AND AROMATIC AMINES IN RELATION TO THE EXTRAPYRAMIDAL SYSTEM.
    WALAAS E; WALAAS O
    Acta Neurol Scand Suppl; 1963; 39(4):SUPPL4:84-94. PubMed ID: 14057524
    [No Abstract]   [Full Text] [Related]  

  • 39. Serum ceruloplasmin levels in healthy persons and in certain pathologic conditions.
    Lyko J
    Acta Med Pol; 1967; 8(3):269-77. PubMed ID: 6062192
    [No Abstract]   [Full Text] [Related]  

  • 40. [Metabolism of ceruloplasmin and copper in the blood in Wilson's disease].
    Kanai M; Nomoto S; Tsukagoshi H; Shindo M
    Rinsho Byori; 1974 Oct; 22(10 Suppl):191. PubMed ID: 4475793
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.